10 completed, 2 unknown, 2 withdrawn, 1 recruiting. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Completed 10, Unknown 2, Withdrawn 2, Recruiting 1 |
Follow Belatacept: new trials by email Literature Review of Belatacept trials Research Report on Belatacept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of the Effects of Belatacept and Anticalcineurins on Endothelial Function in Renal Transplant Patients - <BELAFENDO> Belatacept, anticalcineurins - Kidney Diseases | Phase 4 | Recruiting | University Hospital, Rouen | 44 | 2026-04-30 | 2026-06-09 |
| Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression Belatacept - Kidney Transplant Immunosuppression | Phase 4 | Completed | University of Texas Southwestern Medical Center | 25 | 2021-07-28 | 2026-08-14 |
| Belatacept With Early Steroid Withdrawal rATG and Everolimus in Renal Transplantation (BETTER Trial) Belatacept, Everolimus, mycophenolate mofetil - Kidney Transplant Rejection | Phase 4 | Unknown | University of Cincinnati | 120 | 2021-04-09 | 2021-04-19 |
| Immune Monitoring to Facilitate Belatacept Monotherapy Allosure, Immunosuppression reduction, Trugraf - Kidney Transplant Rejection, Immunosuppression | Phase 4 | Completed | Massachusetts General Hospital | 17 | 2020-02-11 | 2023-12-04 |
| Precision Medicine Offers Belatacept Monotherapy Belatacept - Transplantation | Phase 4 | Withdrawn | University of California, San Francisco | 2019-02-01 | 2022-12-06 | |
| Bela 8 Week Dosing Belatacept - Kidney Transplantation | Phase 4 | Completed | Emory University | 166 | 2015-09-01 | 2020-09-18 |
| Belatacept in Kidney Transplantation of Moderately Sensitized Patients Belatacept, Tacrolimus withdrawal, Plasmapheresis/Intravenous Immunoglobulin G - End Stage Renal Disease, Antibody Mediated Rejection | Phase 4 | Withdrawn | University of Wisconsin, Madison | 2014-09-24 | 2018-12-17 | |
| Belatacept 3 Month Post Transplant Conversion Study belatacept, Tacrolimus, MPA - Transplant; Failure, Kidney, EBV | Phase 4 | Completed | Lorenzo Gallon | 28 | 2014-07-01 | 2023-02-08 |
| Switch From Calcineurin Inhibitor to Belatacept in Pancreas Transplant Recipients Belatacept - Nephrotoxicity | Phase 4 | Completed | Indiana University | 6 | 2014-06-01 | 2017-08-28 |
| Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients Belatacept, Tacrolimus, Mycophenolate - Implant or Graft; Rejection | Phase 4 | Completed | Columbia University | 57 | 2014-06-01 | 2021-02-10 |
| Efficacy of Belatacept in Reducing DSA Belatacept - Kidney Transplantation | Phase 4 | Completed | East Carolina University | 3 | 2013-11-01 | 2017-08-01 |
| Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309) Belatacept - Renal Transplant Rejection | Phase 4 | Completed | University of California, Los Angeles | 20 | 2013-10-01 | 2022-12-13 |
| Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression Belatacept, Tacrolimus - New Onset Diabetes After Transplant, Kidney Transplantation | Phase 4 | Unknown | University of Arizona | 32 | 2013-08-01 | 2013-06-11 |
| Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers Caffeine, Losartan, Omeprazole - Transplant Rejection | Phase 4 | Completed | Bristol-Myers Squibb | 45 | 2013-01-01 | 2014-06-27 |
| Belatacept Early Steroid Withdrawal Trial Alemtuzumab, rabbit antithymocyte globulin, Belatacept - Renal Transplantation | Phase 4 | Completed | University of Cincinnati | 316 | 2012-09-01 | 2026-07-24 |
Delayed Graft Function (2) · Kidney Diseases (1) · Kidney Failure, Chronic (1) · Rejection, Psychology (1)
University of Cincinnati (2) · Bristol-Myers Squibb (1) · Columbia University (1) · East Carolina University (1) · Emory University (1) · Indiana University (1) · Lorenzo Gallon (1) · Massachusetts General Hospital (1) · University Hospital, Rouen (1) · University of Arizona (1) · University of California, Los Angeles (1) · University of California, San Francisco (1) · University of Texas Southwestern Medical Center (1) · University of Wisconsin, Madison (1)
United States (13) · France (1)
Arjang Djamali, M.D. (1) · Asif Sharfuddin, MD (1) · Bruce Kaplan, MD (1) · Cyrus Feizpour, MD (1) · David Wojciechowski, DO (1) · E. Steve Woodle, MD (1) · Flavio Vincenti, MD (1) · Hannah Gilligan, MD (1) · Idelberto Badell, MD (1) · Lorenzo Gallon, MD (1) · Mark A. Hardy, MD (1) · Paul Bolin, MD (1) · Rita R Alloway, PharmD (1) · Suphamai Bunnapradist, M.D. (1)
PMID 31415033, PMID 33583120, PMID 34233921, PMID 36644348, PMID 40704545